drugset / Trial / NCT07303985
The Effects of Remimazolam on Cerebral Blood Flow Following General Anesthesia Induction
RandomizedParallel-groupTriple-blindPrevention
Summary
This study will enroll 40 subjects aged 18 years or older scheduled for elective surgery under general anesthesia with endotracheal intubation. Basic medical history information will be collected. Subjects will be divided into two groups of 20 each: a remimazolam group and a propofol group. The study period will span from one day before surgery to one day after surgery. The study will assess middle cerebral artery cerebral blood flow following general anesthesia induction and postoperative anesthesia recovery.
Timeline
- Start
- 2025-12-29
- Primary completion
- 2026-02-28
- Completion
- 2026-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Propofol | Small molecule | 2 mg/kg | Intravenous |
| Subject | Remimazolam | Small molecule | 0.3 mg/kg | Intravenous |
Indications
No indication recorded.